Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Cellectis S.A. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +3 vs. Q3 2023
- Shares held
- 9.82M
- −1.66M (−14.5%) vs. Q3 2023
- Total value
- $30.2M
- +$12.1M (+66.7%) vs. Q3 2023
- New holders
- 9
- 6 more added
- Sold out
- 6
- 7 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 200 | $0 | 0.00% | +200 | New |
| Bank of America Corp | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 10 | $32 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 13 | $40 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $95 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 40 | $123 | 0.00% | +40 | New |
| JPMorgan Chase & Co | 83 | $256 | 0.00% | −4,940−98.3% | Reduced |
| UBS Group AG | 100 | $308 | 0.00% | −3,935−97.5% | Reduced |
| Group One Trading, L.P. | 330 | $1.02K | 0.00% | +330 | New |
| POM Investment Strategies, LLC | 495 | $1.52K | 0.00% | +495 | New |
| Baystate Wealth Management LLC | 500 | $1.54K | 0.00% | +500 | New |
| Allworth Financial LP | 500 | $1.54K | 0.00% | +500 | New |
| Tennessee Valley Asset Management Partners | 2,430 | $7.48K | 0.00% | +2,430 | New |
| BlackRock Inc. | 2,755 | $8.48K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $11.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 3,855 | $11.9K | 0.00% | +885+29.8% | Added |
| Qube Research & Technologies Ltd | 4,477 | $13.8K | 0.00% | +4,437+11,092.5% | Added |
| Advisor Group Holdings, Inc. | 4,580 | $14.1K | 0.00% | −4,390−48.9% | Reduced |
| Geode Capital Management, LLC | 10,776 | $33.2K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 14,294 | $44.0K | 0.00% | −1,250−8.0% | Reduced |
| BNP Paribas Arbitrage, SA | 15,800 | $48.7K | 0.00% | +4,856+44.4% | Added |
| Citadel Advisors LLC | 17,784 | $54.8K | 0.00% | −16,516−48.2% | Reduced |
| Susquehanna International Group, LLP | 19,524 | $60.1K | 0.00% | +19,524 | New |
| Two Sigma Investments, LP | 52,247 | $160.9K | 0.00% | +52,247 | New |
| LPL Financial LLC | 72,187 | $222.3K | 0.00% | +8,530+13.4% | Added |
| Morgan Stanley | 76,225 | $234.8K | 0.00% | +8,633+12.8% | Added |
| Oppenheimer & Co Inc | 133,143 | $410.1K | 0.01% | +11,723+9.7% | Added |
| KBC Group NV | 163,447 | $503.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 226,875 | $699.0K | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 399,627 | $1.23M | 0.00% | −256,973−39.1% | Reduced |
| Baillie Gifford & Co | 816,643 | $2.52M | 0.00% | −347,366−29.8% | Reduced |
| Credit Suisse AG | 1,438,255 | $4.43M | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $5.69M | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 4,487,293 | $13.8M | 1.79% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,095,966−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −47,154−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −56−100.0% | Sold out |